Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Polyphenols, a diverse group of phytochemicals found in foods such as tea, fruits, vegetables, and herbs, have been investigated for their potential hepatoprotective effects, including applications in hepatitis. Scientific research, primarily preclinical and some small-scale clinical studies, suggests that polyphenols such as epigallocatechin gallate (EGCG) from green tea, resveratrol, and curcumin possess anti-inflammatory, antioxidant, and antiviral properties that can be beneficial for liver health. These compounds may help reduce oxidative stress and inhibit inflammatory pathways implicated in liver injury and hepatitis progression. In vitro and animal studies have shown that certain polyphenols can suppress hepatitis B and C virus replication and mitigate liver fibrosis. However, clinical evidence in humans is still limited and often inconclusive, with most studies being small, of short duration, or lacking rigorous controls. There have also been concerns about potential hepatotoxicity from excessive intake of isolated polyphenol supplements, particularly green tea extract. While polyphenols are not established as a primary treatment for hepatitis, dietary intake and supplementation are being explored as adjunctive strategies. In summary, moderate scientific evidence supports a potential benefit of mixed polyphenols for liver health and hepatitis, primarily based on mechanistic and animal data, but more robust, large-scale clinical trials are needed to confirm efficacy and safety in hepatitis patients.

More about Polyphenols (mixed)
More about Hepatitis

Other ingredients used for Hepatitis

Other health conditions supported by Polyphenols (mixed)

Products containing Polyphenols (mixed)